241 related articles for article (PubMed ID: 33515844)
21. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
[TBL] [Abstract][Full Text] [Related]
22. First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America.
Garelli F; Fushimi E; Rosales N; Arambarri D; Mendoza L; Serafini MC; Moscoso-Vásquez M; Stasi M; Duette P; García-Arabehety J; Giunta JN; De Battista H; Sánchez-Peña R; Grosembacher L
J Diabetes Sci Technol; 2023 Jul; 17(4):1008-1015. PubMed ID: 35549733
[TBL] [Abstract][Full Text] [Related]
23. A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Haidar A; Tsoukas MA; Bernier-Twardy S; Yale JF; Rutkowski J; Bossy A; Pytka E; El Fathi A; Strauss N; Legault L
Diabetes Care; 2020 Mar; 43(3):597-606. PubMed ID: 31974099
[TBL] [Abstract][Full Text] [Related]
24. Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell.
Wang Y; Dassau E; Zisser H; Jovanovič L; Doyle FJ
Diabetes Technol Ther; 2010 Nov; 12(11):879-87. PubMed ID: 20879966
[TBL] [Abstract][Full Text] [Related]
25. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
Sánchez-Peña R; Colmegna P; Garelli F; De Battista H; García-Violini D; Moscoso-Vásquez M; Rosales N; Fushimi E; Campos-Náñez E; Breton M; Beruto V; Scibona P; Rodriguez C; Giunta J; Simonovich V; Belloso WH; Cherñavvsky D; Grosembacher L
J Diabetes Sci Technol; 2018 Sep; 12(5):914-925. PubMed ID: 29998754
[TBL] [Abstract][Full Text] [Related]
26. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
27. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jafar A; Devaux M; Ghanbari M; Rabasa-Lhoret R
Diabetes Care; 2023 Jul; 46(7):1372-1378. PubMed ID: 37134305
[TBL] [Abstract][Full Text] [Related]
28. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
[TBL] [Abstract][Full Text] [Related]
29. Dynamic Rule-Based Algorithm to Tune Insulin-on-Board Constraints for a Hybrid Artificial Pancreas System.
Bertachi A; Biagi L; Beneyto A; Vehí J
J Healthc Eng; 2020; 2020():1414597. PubMed ID: 32399164
[TBL] [Abstract][Full Text] [Related]
30. Super-twisting-based meal detector for type 1 diabetes management: Improvement and assessment in a real-life scenario.
Faccioli S; Sala-Mira I; Díez JL; Facchinetti A; Sparacino G; Del Favero S; Bondia J
Comput Methods Programs Biomed; 2022 Jun; 219():106736. PubMed ID: 35338888
[TBL] [Abstract][Full Text] [Related]
31. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
[TBL] [Abstract][Full Text] [Related]
32. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
[TBL] [Abstract][Full Text] [Related]
33. Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Song L; Liu C; Yang W; Zhang J; Kong X; Zhang B; Chen X; Wang N; Shen D; Li Z; Jin X; Shuai Y; Wang Y
Comput Methods Programs Biomed; 2020 Jul; 191():105416. PubMed ID: 32146213
[TBL] [Abstract][Full Text] [Related]
34. Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.
Tsoukas MA; Cohen E; Legault L; von Oettingen JE; Yale JF; Vallis M; Odabassian M; El Fathi A; Rutkowski J; Jafar A; Ghanbari M; Gouchie-Provencher N; René J; Palisaitis E; Haidar A
Diabetes Obes Metab; 2021 Sep; 23(9):2090-2098. PubMed ID: 34047449
[TBL] [Abstract][Full Text] [Related]
35. A practical approach based on learning-based model predictive control with minimal prior knowledge of patients for artificial pancreas.
Lim MH; Kim S
Comput Methods Programs Biomed; 2023 Oct; 240():107694. PubMed ID: 37413705
[TBL] [Abstract][Full Text] [Related]
36. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
Gingras V; Rabasa-Lhoret R; Messier V; Ladouceur M; Legault L; Haidar A
Diabetes Metab; 2016 Feb; 42(1):47-54. PubMed ID: 26072052
[TBL] [Abstract][Full Text] [Related]
38. Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy.
Meneghetti L; Facchinetti A; Favero SD
IEEE Trans Biomed Eng; 2021 Jan; 68(1):170-180. PubMed ID: 32746034
[TBL] [Abstract][Full Text] [Related]
39. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
Buckingham BA; Christiansen MP; Forlenza GP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Sep; 20(9):585-595. PubMed ID: 30070928
[TBL] [Abstract][Full Text] [Related]
40. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
